Richard Y Chung

Title: **Inventor Profile: Richard Y. Chung**

Introduction

Richard Y. Chung is a distinguished inventor based in Boston, Massachusetts. With a focus on biomedical innovations, he has made significant contributions to the field of cancer research. His expertise is particularly noted in the development of targeted therapies that harness the potential of herpes viral mutants.

Latest Patents

Richard Y. Chung holds two patents that showcase his innovative approach to cancer treatment. His latest patent, titled "Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression," relates to herpes viral mutants designed to selectively target tumor cells. This invention utilizes tumor-specific and cell-specific promoters to drive the expression of the herpes γ 34.5 gene, providing a promising avenue for targeted cancer therapies.

Career Highlights

Richard is affiliated with the General Hospital Corporation, where he continues to work on advancing his research and inventions in the biomedical arena. His background in molecular biology and virology has enabled him to explore novel solutions aimed at improving treatment outcomes for cancer patients.

Collaborations

In his professional journey, Richard Y. Chung collaborates with notable colleagues, including Dr. E. Antonio Chiocca. Their combined expertise enhances the research efforts in developing effective therapies that target cancerous cells while minimizing effects on healthy tissues.

Conclusion

Richard Y. Chung is a prominent figure in the realm of biomedical innovation. His patents reflect a deep commitment to advancing cancer treatment through selective targeting mechanisms. As he continues to work with leading professionals and institutions, his contributions to the field remain invaluable.